- Home
- NECB vs AVIR Comparison
NECB vs AVIR Comparison
Compare NECB & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NECB | AVIR |
|---|---|---|
| Founded | 1934 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.0M | 413.1M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NECB | AVIR |
|---|---|---|
| Price | $27.77 | $5.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $30.00 | $9.42 |
| AVG Volume (30 Days) | 33.1K | ★ 271.1K |
| Earning Date | 10-26-2026 | 11-11-2026 |
| Dividend Yield | ★ 3.70% | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ 1.46 | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | $2.26 | N/A |
| Revenue Next Year | $18.16 | N/A |
| P/E Ratio | $18.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.27 | $2.87 |
| 52 Week High | $28.94 | $6.45 |
Technical Indicators
Market Signals| Indicator | NECB | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 61.44 | 44.42 |
| Support Level | $25.83 | $5.01 |
| Resistance Level | $28.94 | $5.76 |
| Average True Range (ATR) | 0.63 | 0.21 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 92.36 | 22.46 |
Price Performance
Historical ComparisonAbout NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.